Pharmaxis Ltd operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pharmaxis Ltd with three other
companies in this sector in the United States:
Bioanalytical Systems, Inc.
sales of $20.44 million
Clinuvel Pharmaceuticals Limited
of which 100%
was Biotechnology), and
of which 67%
Sales fell dramatically in 2016:
During the year ended June of 2016, sales at
Pharmaxis Ltd were $13.50 million.
decrease of 72.2%
versus 2015, when the company's sales were $48.51 million.
Contributing to the drop in overall sales was the 94.4% decline
in New Drug Development, from $33.60 million to $1.88 million.
There were also decreases in sales in
Bronchitol and Aridol (down 25.3% to $10.84 million)
Corporate (down 27.1% to $230,484.36 )